News

MannKind Corporation to Present at Investor Conferences

MannKind Corporation to Present at Investor Conferences

MannKind Corporation to Present at Investor Conferences

MannKind Corporation (Nasdaq: MNKD) is dedicated to developing and commercializing innovative inhaled therapeutic products and devices for patients suffering from endocrine and orphan lung diseases. The company's Chief Executive Officer, Michael Castagna, PharmD, along with Chief Financial Officer, Chris Prentiss, will share important updates at several upcoming investor conferences.

Upcoming Presentation Events

In the coming weeks, executives from MannKind Corporation will engage in fireside chats at prominent investor conferences. These events present a valuable opportunity for interested individuals to gain insights into the company's strategic direction.

2024 Wells Fargo Healthcare Conference

The first event on the agenda is the 2024 Wells Fargo Healthcare Conference, which will take place in Boston. Scheduled for Wednesday, September 4, at 11:00 a.m. Eastern Time, this session will provide attendees with an overview of the latest developments at MannKind.

Morgan Stanley Annual Global Healthcare Conference

Next, MannKind will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Friday, September 6, at 7:00 a.m. Eastern Time. This conference will offer further insights into the company's initiatives.

H.C. Wainwright Annual Global Investment Conference

Finally, MannKind executives will attend the H.C. Wainwright 26th Annual Global Investment Conference in New York on Tuesday, September 10, at 9:30 a.m. Eastern Time. This event will serve as another platform to discuss the company's innovations and future plans.

Audio Webcasts and Access

For those who cannot attend these sessions in person, MannKind Corporation will provide links for live audio webcasts on their official website. Additionally, an archived version will be available for about 30 days after each conference, allowing investors and stakeholders to review the discussions at their convenience.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) is committed to the development and commercialization of innovative inhaled therapeutic products. Their mission focuses on addressing serious unmet medical needs for individuals living with endocrine and orphan lung diseases. Current advancements include formulations and devices targeting conditions such as diabetes, nontuberculous mycobacterial lung disease, pulmonary fibrosis, and pulmonary hypertension.

By utilizing cutting-edge dry-powder formulations and inhalation devices, MannKind enables rapid and convenient medication delivery, specifically tailored to achieve either local or systemic effects based on the required indication. This innovative approach underscores their dedication to enhancing the quality of life for patients.

Innovative Technologies and Commitments

MannKind stands at the forefront of the medical technology sector, led by a passionate team known as Mannitarians, who are fully engaged in their mission. The company combines its formulation capabilities with device engineering expertise to help alleviate the challenges posed by complex diseases.

MannKind Corporation aims to empower individuals to take greater control over their health, ultimately allowing them the freedom to participate fully in life. As the industry continues to evolve, the company plans to maintain its focus on advancing therapeutic innovations that truly make a difference.

Stay Connected for Updates

For more information regarding MannKind Corporation's initiatives, products, and investor updates, please visit their official website. Stakeholders are also encouraged to follow the company on various social media platforms to stay informed about the latest developments.

Frequently Asked Questions

What is MannKind Corporation known for?

MannKind Corporation is recognized for its innovative inhaled therapeutic products and devices designed to address serious unmet medical needs.

Who will present at the upcoming conferences?

The conferences will feature presentations by Michael Castagna, PharmD, the CEO, and Chris Prentiss, the CFO.

Where can I access the live audio webcasts?

Live audio webcasts will be accessible through MannKind Corporation’s official website during the conferences.

What are the key diseases MannKind is targeting?

MannKind is focused on diseases such as diabetes, nontuberculous mycobacterial lung disease, pulmonary fibrosis, and pulmonary hypertension.

How can investors learn more about MannKind Corporation?

Investors can find more information by visiting the company's website and following them on social media for updates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 26

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
Stent or Meds? Long-Term Study Questions Benefits

Updated Category News Views 86

The Long Game in Cardiology There's this long-standing debate in cardiology about whether sticking a metal stent in an artery actually prevents heart attacks or just looks impressive. Well, after chewing on 25 years of data from the COURAGE trial, CU Anschutz researchers led by Dr. Neel Butala have thrown a curveball — these stents might not be as life-saving as many...

Continue Reading
Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

Updated Category News Views 80

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Continue Reading
Shorr Packaging's Sustainable Edge: EcoVadis Silver Triumph

Updated Category News Views 103

EcoVadis Silver Badge: Shorr's Green Path Imagine this: Shorr Packaging strutting around with an EcoVadis Silver Badge pinned to its chest for not one, not two, but three years now. That's right, Shorr Packaging's been elbowing its way to the top tier with their sustainability drive, ranked in the 93rd percentile. For those not keeping score, that's top-notch, considering...

Continue Reading
Classys Rides Revenue Surge, Eyes China Growth

Updated Category News Views 48

Strong Numbers, But There's More to Unpack Nine months into 2026, Classys Inc. ain't exactly putting up shabby numbers. They've rolled in with KRW 275.7 billion like it was a stroll in the park, marking a sturdy 13% jump from last year. Yet, with all this, their operating profit has taken a 9.4% spill. It's a mixed bag, folks, and Classys is gearing up for a massive...

Continue Reading
Optikos Secures CMMC Level 2, Eyeing Defense Market

Updated Category News Views 73

Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...

Continue Reading
SPOC Energy's Hiring Push Signals Growth Surge

Updated Category News Views 39

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Continue Reading
55 Broad Street's New Face: A $500M Revamp with RXR

Updated Category News Views 106

Recapitalization: Changing the Game for 55 Broad Street Here we are again, watching yet another iconic Manhattan building redefine itself. This time, it's 55 Broad Street's turn, as Silverstein, MetroLoft, and RXR shake things up. Newmark Group, Inc. (NASDAQ: NMRK), the fiery real estate power player, orchestrated a dynamic transaction involving a $305 million financing...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 72

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading
The Melt Expands with Key Texas Franchise Deal

Updated Category News Views 83

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in CRH: An Insightful Journey Over Five Years

Updated Category News Views 190

Understanding CRH's Stock Journey Over Five Years CRH (NYSE: CRH) has had a remarkable performance, outpacing the market by an impressive 8.76% annually, leading to an average return of 21.19%. Currently, the company boasts a substantial market capitalization of $72.57 billion. This impressive growth showcases the strength of CRH in the competitive market. The Value of...

Continue Reading
Josh Allen's Exciting New Role with New Era Cap Unveiled

Updated Category News Views 374

Josh Allen Partners with New Era Cap in Unique Role Buffalo Bills quarterback Josh Allen is taking his engagement with New Era Cap to the next level, stepping into the role of "Director of Billustration." This unique title not only signifies a deeper partnership but also includes equity ownership in the renowned sports and lifestyle brand. Allen, who has been associated...

Continue Reading
LHV Group Expands Share Acquisition Strategy on Nasdaq

Updated Category News Views 176

LHV Group's Strategic Share Acquisition on Nasdaq Tallinn In a bold move, LHV Group has embarked on a significant journey of acquiring its own shares, with transactions recorded from the period of 03 to 09 October 2025. Engaging the investment community, LHV Group continues to strengthen its market presence on the Nasdaq Tallinn Stock Exchange. Details of the Acquisition...

Continue Reading
Allegro MicroSystems to Showcase Innovations at TMT Summit

Updated Category News Views 98

Allegro MicroSystems to Showcase Innovations at TMT Summit Allegro MicroSystems, Inc. is making waves in the semiconductor industry as a global leader focused on power and sensing solutions. The company recently announced its participation in a prominent event, Wells Fargo’s 8th Annual TMT Summit, slated for December. During this summit, Allegro will take the stage to...

Continue Reading
CACI International Inc Achieves New Heights in Stock Performance

Updated Category News Views 172

CACI International Inc hit a historic peak with its stock soaring to $498.24, reflecting a staggering 58.66% increase over the past year. This climb isn’t just a number; it’s a testament to the company's stellar performance and strong investor sentiment in an often volatile defense and IT sector. CACI's Momentum: Strategic Contracts Fueling Growth Recent developments...

Continue Reading